Medical Condition News

RSS

People over 40 with type 1 diabetes have worse outcomes from COVID-19, shows study

Adults with type 1 diabetes need to be extra cautious of COVID-19 as they are more likely to be hospitalized and die, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

28 Sep 2021

Clinical study tests novel topical corneal epithelial stem cell-derived product for treating dry eye disease

Several studies conducted over the last decade have concluded that dry eye disease (DED) affects up to 50% of the U.S. population, creating a liability for the nation's health care system that is estimated to exceed $50 billion annually.

28 Sep 2021

Females more likely to report depressive symptoms than males in late life

Depression affects up to one in four people but is often associated with young adults in the public consciousness.

28 Sep 2021

The effectiveness of mRNA BNT162b2 vaccine in reducing severe COVID-19: Evidence from Germany

A new study discusses the epidemiology of the outbreak in German nursing homes and the preventive measures undertaken.

28 Sep 2021

Depression in early adulthood may lead to cognitive decline in old age

While research has shown that poor cardiovascular health can damage blood flow to the brain increasing the risk for dementia, a new study led by UC San Francisco indicates that poor mental health may also take its toll on cognition.

28 Sep 2021

UNLV neuroscientists bolster the connection between Type II diabetes and Alzheimer's disease

A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer's disease.

28 Sep 2021

Novel mind-body intervention found to be highly beneficial for treating chronic back pain

Chronic back pain is the leading cause of disability worldwide. In the United States, patients spend up to $300 billion each year to treat the condition, according to a 2012 study published in the Journal of Pain.

28 Sep 2021

BostonGene and MD Anderson collaborate to advance the development of multiplatform biomarker signatures

The University of Texas MD Anderson Cancer Center and BostonGene Corporation today announced a strategic alliance to advance the development and clinical integration of multiplatform biomarker signatures.

28 Sep 2021

Mass Eye and Ear researcher receives P50 NIH grant to establish new center for neurological voice disorders

Kristina Simonyan, MD, PhD, Dr med, director of laryngology research at Mass Eye and Ear, has been awarded an $11.9 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communicable Disorders of the National Institute of Health to form a new multidisciplinary center across four academic medical institutions that will be committed to conducting research on laryngeal dystonia and voice tremor, two debilitating neurological voice disorders.

28 Sep 2021

Salt substitutes are effective in reducing stroke, major cardiovascular events

A salt substitute that includes less sodium reduced rates of stroke and heart attack in rural China, according to a trial published in the New England Journal of Medicine.

28 Sep 2021

Feeling happy about life reduces the odds of cognitive impairment in older adults

Feeling happy about life slowed the cognitive decline among older adults in China, a new 12-year study suggests.

28 Sep 2021

U-M lab receives $13.2 million NIDA grant to optimize interventions for substance abuse disorders

A University of Michigan lab focused on developing cutting-edge methods to inform effective interventions for drug abuse, HIV and other chronic conditions has been awarded a $13.2 million grant from the National Institute on Drug Abuse.

28 Sep 2021

Researchers develop efficient approach to identify 3D features of post-infarction scarring

A multidisciplinary team of scientists based at the Universidad de Valladolid and the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has developed a highly efficient method for identifying the 3-dimensional features of the scar tissue formed after a myocardial infarction.

28 Sep 2021

Research uncovers exclusion of people with disabilities from COVID-19 planning and relief efforts

Three new publications by Inclusive Futures have revealed how people with disabilities were not only disproportionately and 'catastrophically' excluded from COVID-19 pandemic planning and relief efforts, but that representative disability groups were vital in aiding those left behind by the systems that are supposed to support them.

28 Sep 2021

Primary sclerosing cholangitis: Therapy with synthetic bile acid acts directly on the immune system

Primary Sclerosing Cholangitis (PSC) is a rare, chronic inflammatory disease of the bile ducts and is difficult to treat. Studies conducted by the Division of Gastroenterology and Hepatology at MedUni Wien under the guidance of Michael Trauner (Department of Internal Medicine III) were able to show positive effects from the administration of synthetically produced bile acids and bile acid receptor agonists.

28 Sep 2021

Classic antidepressants show potential to enhance modern cancer treatments

Classic antidepressants could help improve modern cancer treatments. They slowed the growth of pancreatic and colon cancers in mice, and when combined with immunotherapy, they even stopped the cancer growth long-term.

28 Sep 2021

Evidence of persisting autoreactivity in post-acute sequelae of SARS-CoV-2 infection?

It has been demonstrated in recent studies that there is a significant breadth of emerging autoreactivity associated with severe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. More specifically, researchers from Emory University have identified a relaxation of peripheral tolerance within early antibody secretion cells that arise in individuals infected with SARS-CoV-2, as important drivers of those responses.

28 Sep 2021

Most adults prefer monitoring blood pressure at home, research finds

Adults who needed to track their blood pressure regularly to confirm or refute a hypertension diagnosis preferred monitoring blood pressure at home versus at a clinic, kiosk or with a 24-hour wearable device, according to preliminary research presented today at the American Heart Association's Hypertension Scientific Sessions 2021.

27 Sep 2021

Drug treatment decreases risk for severe COVID-19 outcomes in patients with Type 2 diabetes

A type of drug already used to treat obesity and Type 2 diabetes, when taken six months prior to the diagnosis of COVID-19, was associated with a decreased risk of hospitalization, respiratory complications and death in COVID-19 patients with Type 2 diabetes, according to researchers at Penn State College of Medicine.

27 Sep 2021

Scientists discover novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia

A new type of targeting chaperon protein HSP70 inhibitor QL47 was recently discovered by a team led by Prof. LIU Qingsong from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences to treat FLT3-ITD-positive acute myeloid leukemia (AML).

27 Sep 2021

Medical Condition News

People over 40 with type 1 diabetes have worse outcomes from COVID-19, shows study

Clinical study tests novel topical corneal epithelial stem cell-derived product for treating dry eye disease

Females more likely to report depressive symptoms than males in late life

The effectiveness of mRNA BNT162b2 vaccine in reducing severe COVID-19: Evidence from Germany

Depression in early adulthood may lead to cognitive decline in old age

UNLV neuroscientists bolster the connection between Type II diabetes and Alzheimer's disease

Novel mind-body intervention found to be highly beneficial for treating chronic back pain

BostonGene and MD Anderson collaborate to advance the development of multiplatform biomarker signatures

Mass Eye and Ear researcher receives P50 NIH grant to establish new center for neurological voice disorders

Salt substitutes are effective in reducing stroke, major cardiovascular events

Feeling happy about life reduces the odds of cognitive impairment in older adults

U-M lab receives $13.2 million NIDA grant to optimize interventions for substance abuse disorders

Researchers develop efficient approach to identify 3D features of post-infarction scarring

Research uncovers exclusion of people with disabilities from COVID-19 planning and relief efforts

Primary sclerosing cholangitis: Therapy with synthetic bile acid acts directly on the immune system

Classic antidepressants show potential to enhance modern cancer treatments

Evidence of persisting autoreactivity in post-acute sequelae of SARS-CoV-2 infection?

Most adults prefer monitoring blood pressure at home, research finds

Drug treatment decreases risk for severe COVID-19 outcomes in patients with Type 2 diabetes

Scientists discover novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News